Farkas Klaudia & Molnár Tamás. (2018). A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease.
Chicago Style (17th ed.) CitationFarkas Klaudia and Molnár Tamás. A Review on Biosimilar Infliximab, CT-P13, in the Treatment of Inflammatory Bowel Disease. 2018.
MLA idézésFarkas Klaudia and Molnár Tamás. A Review on Biosimilar Infliximab, CT-P13, in the Treatment of Inflammatory Bowel Disease. 2018.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..